Karydas Daphne, Chief Financial Officer at Syndax Pharmaceuticals, holds ― shares in Syndax Pharmaceuticals (Ticker: SNDX), holds ― shares in Logicbio Therapeutics (Ticker: ~LOGC), holds 0.00 shares in Mineralys Therapeutics, Inc. (Ticker: MLYS). Most recently, Karydas Daphne ― shares of Syndax Pharmaceuticals on ― for an estimated value of ―.
Karydas Daphne latest transaction was an Uninformative Buy of ―.
What was Karydas Daphne's most profitable transaction?
Karydas Daphne’s most profitable transaction was an Informative Sell of MLYS stock on November 13, 2025. The return on the trade was 7.70%.
What is Karydas Daphne's role in Syndax Pharmaceuticals?
Karydas Daphne's role in Syndax Pharmaceuticals is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.